ICON plc is a global clinical research organisation founded in Dublin in 1990, providing outsourced clinical development and commercialisation services, including AI and data-driven technology solutions.
ICON plc is a global clinical research organisation that provides outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government clients. Founded in Dublin in 1990 by a team of five, the company employs nearly 40,000 people across 95 locations in 55 countries, and has been in operation for over 35 years.
The company's work spans end-to-end clinical development services across a broad range of therapeutic areas, commercialisation services supporting the launch of drugs and devices, and technology solutions that combine experience and expertise with artificial intelligence, data and analytics. Its stated focus is on reducing time to market, cutting costs and improving quality for clients.
In 2024 the company supported 1,465 studies involving nearly 48,000 patients, worked with 406 customers, and contributed to 18 drug approvals. Growth has come both organically and through strategic acquisitions.
ICON plc describes itself as a mission-driven organisation, with a large distributed workforce working toward helping clients bring life-saving drugs and devices to market faster. Its technical domains include clinical development technology solutions, AI, data and analytics, and drug and device commercialisation.
